Clemens Ruppert
Giessen, HE 35392, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts.
Journal: Science translational medicine
Published: May 13, 2026
Deficiency of Smooth Muscle Adar1 Exacerbates Vascular Remodeling and Pulmonary Hypertension.
Journal: Circulation research
Published: October 22, 2025
Deep inflations maintain surfactant function and alveolar fluid balance in lungs with reduced surfactant protein B levels during mechanical ventilation.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: October 16, 2025
Vascular smooth muscle cell-derived osteoprotegerin drives pulmonary arterial hypertension via AKT activation and is attenuated by monoclonal antibody therapy.
Journal: Cardiovascular research
Published: October 09, 2025
Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosis.
Journal: Signal transduction and targeted therapy
Published: August 22, 2025
Living human lung slices for ex vivo modelling of lung cancer.
Journal: JCI insight
Published: July 29, 2025
Zinc-mediated Inhibition of Soluble Epoxide Hydrolase Promotes Pulmonary Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: June 12, 2025
Reduced surfactant protein B levels impede unfolding of the pulmonary blood-gas barrier during inspiration in mice.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: June 05, 2025
RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices.
Journal: Respiratory research
Published: May 15, 2025
Last Updated: 09/26/2026